nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—IGF1R—lung cancer	0.462	1	CbGaD
Masoprocol—IGF1R—Crizotinib—lung cancer	0.383	0.924	CbGbCtD
Masoprocol—CYP19A1—Paclitaxel—lung cancer	0.0314	0.0758	CbGbCtD
Masoprocol—LTB4R—respiratory system—lung cancer	0.00312	0.106	CbGeAlD
Masoprocol—IGF1R—respiratory system—lung cancer	0.00258	0.0876	CbGeAlD
Masoprocol—LTB4R—bronchus—lung cancer	0.00257	0.0874	CbGeAlD
Masoprocol—LTB4R—trachea—lung cancer	0.00231	0.0784	CbGeAlD
Masoprocol—IGF1R—epithelium—lung cancer	0.00215	0.0732	CbGeAlD
Masoprocol—LTB4R—bone marrow—lung cancer	0.00183	0.0622	CbGeAlD
Masoprocol—LTB4R—lung—lung cancer	0.00166	0.0564	CbGeAlD
Masoprocol—IGF1R—Irinotecan—Topotecan—lung cancer	0.00162	0.497	CbGdCrCtD
Masoprocol—CYP2J2—bronchus—lung cancer	0.00144	0.0489	CbGeAlD
Masoprocol—ALOX5—respiratory system—lung cancer	0.00138	0.0468	CbGeAlD
Masoprocol—IGF1R—lung—lung cancer	0.00137	0.0465	CbGeAlD
Masoprocol—IGF1R—Topotecan—Irinotecan—lung cancer	0.00135	0.413	CbGdCrCtD
Masoprocol—CYP2J2—trachea—lung cancer	0.00129	0.0439	CbGeAlD
Masoprocol—CYP2J2—cardiac atrium—lung cancer	0.00121	0.0412	CbGeAlD
Masoprocol—LTB4R—lymph node—lung cancer	0.00113	0.0385	CbGeAlD
Masoprocol—ALOX5—bronchus—lung cancer	0.00113	0.0385	CbGeAlD
Masoprocol—IGF1R—lymph node—lung cancer	0.000936	0.0318	CbGeAlD
Masoprocol—CYP2J2—lung—lung cancer	0.000928	0.0315	CbGeAlD
Masoprocol—ALOX5—bone marrow—lung cancer	0.000807	0.0274	CbGeAlD
Masoprocol—ALOX5—lung—lung cancer	0.000731	0.0248	CbGeAlD
Masoprocol—ALOX5—lymph node—lung cancer	0.0005	0.017	CbGeAlD
Masoprocol—CYP19A1—lymph node—lung cancer	0.000346	0.0117	CbGeAlD
Masoprocol—IGF1R—Idarubicin—Doxorubicin—lung cancer	0.000293	0.0898	CbGdCrCtD
Masoprocol—CYP2J2—Metabolism—ENO1—lung cancer	2.46e-05	0.000271	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ABCG2—lung cancer	2.46e-05	0.000271	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ADCY1—lung cancer	2.46e-05	0.000271	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.46e-05	0.00027	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—PTEN—lung cancer	2.45e-05	0.00027	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.42e-05	0.000267	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ENO2—lung cancer	2.42e-05	0.000266	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HPGDS—lung cancer	2.42e-05	0.000266	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CKB—lung cancer	2.42e-05	0.000266	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPP2R1B—lung cancer	2.4e-05	0.000264	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AVP—lung cancer	2.39e-05	0.000263	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CB—lung cancer	2.38e-05	0.000262	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.37e-05	0.000261	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTT1—lung cancer	2.34e-05	0.000258	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—EP300—lung cancer	2.34e-05	0.000257	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GCLC—lung cancer	2.32e-05	0.000255	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP2A6—lung cancer	2.32e-05	0.000255	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.31e-05	0.000254	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF1R—lung cancer	2.3e-05	0.000253	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCL8—lung cancer	2.29e-05	0.000252	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTM2—lung cancer	2.27e-05	0.00025	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CNDP2—lung cancer	2.27e-05	0.00025	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HES1—lung cancer	2.26e-05	0.000248	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—STK11—lung cancer	2.24e-05	0.000247	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—lung cancer	2.22e-05	0.000244	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—RAF1—lung cancer	2.21e-05	0.000244	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MTMR3—lung cancer	2.21e-05	0.000243	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP2E1—lung cancer	2.21e-05	0.000243	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ENO1—lung cancer	2.2e-05	0.000242	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.19e-05	0.000241	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—IL2—lung cancer	2.19e-05	0.00024	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NQO1—lung cancer	2.19e-05	0.00024	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FOXO3—lung cancer	2.17e-05	0.000238	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CB—lung cancer	2.16e-05	0.000238	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.16e-05	0.000238	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PGAM1—lung cancer	2.15e-05	0.000237	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.14e-05	0.000235	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.12e-05	0.000233	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCL8—lung cancer	2.08e-05	0.000228	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ERBB3—lung cancer	2.06e-05	0.000227	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2A7—lung cancer	2.05e-05	0.000226	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MYC—lung cancer	2.04e-05	0.000224	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AVP—lung cancer	2.03e-05	0.000223	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SDC4—lung cancer	2.01e-05	0.000221	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—lung cancer	1.99e-05	0.000219	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL2—lung cancer	1.99e-05	0.000218	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TERT—lung cancer	1.98e-05	0.000218	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP2E1—lung cancer	1.97e-05	0.000217	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—STK11—lung cancer	1.97e-05	0.000217	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NQO1—lung cancer	1.95e-05	0.000214	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FGFR1—lung cancer	1.92e-05	0.000211	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HES1—lung cancer	1.92e-05	0.000211	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.91e-05	0.00021	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HIF1A—lung cancer	1.89e-05	0.000208	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.89e-05	0.000208	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—KRAS—lung cancer	1.88e-05	0.000207	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.85e-05	0.000203	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—RRM1—lung cancer	1.83e-05	0.000201	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTA3—lung cancer	1.83e-05	0.000201	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APOA1—lung cancer	1.83e-05	0.000201	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTP1—lung cancer	1.82e-05	0.0002	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KDR—lung cancer	1.81e-05	0.000199	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CAT—lung cancer	1.77e-05	0.000195	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.76e-05	0.000194	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—STK11—lung cancer	1.76e-05	0.000193	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ERBB3—lung cancer	1.75e-05	0.000193	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ABCB1—lung cancer	1.73e-05	0.00019	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—B4GALT5—lung cancer	1.72e-05	0.000189	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TYMS—lung cancer	1.69e-05	0.000186	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TERT—lung cancer	1.68e-05	0.000185	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTA4—lung cancer	1.68e-05	0.000184	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTM1—lung cancer	1.68e-05	0.000184	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TP53—lung cancer	1.67e-05	0.000184	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CG—lung cancer	1.67e-05	0.000183	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KIT—lung cancer	1.67e-05	0.000183	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APC—lung cancer	1.67e-05	0.000183	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—NRAS—lung cancer	1.67e-05	0.000183	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.65e-05	0.000181	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGF—lung cancer	1.65e-05	0.000181	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.64e-05	0.00018	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGFR1—lung cancer	1.63e-05	0.00018	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTA2—lung cancer	1.63e-05	0.00018	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTP1—lung cancer	1.62e-05	0.000179	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HIF1A—lung cancer	1.61e-05	0.000177	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—MAPK3—lung cancer	1.6e-05	0.000176	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP1A1—lung cancer	1.59e-05	0.000175	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—POMC—lung cancer	1.59e-05	0.000174	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CAT—lung cancer	1.58e-05	0.000174	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTA1—lung cancer	1.57e-05	0.000173	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ERCC2—lung cancer	1.57e-05	0.000173	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.57e-05	0.000173	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—BRAF—lung cancer	1.57e-05	0.000172	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCC3—lung cancer	1.56e-05	0.000171	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APOA1—lung cancer	1.55e-05	0.000171	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6R—lung cancer	1.55e-05	0.00017	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CREBBP—lung cancer	1.55e-05	0.00017	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KDR—lung cancer	1.54e-05	0.000169	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ABCB1—lung cancer	1.54e-05	0.000169	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—EGFR—lung cancer	1.52e-05	0.000167	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TYMS—lung cancer	1.51e-05	0.000166	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AKR1C1—lung cancer	1.51e-05	0.000166	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTM1—lung cancer	1.49e-05	0.000164	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAP2K1—lung cancer	1.47e-05	0.000162	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CD—lung cancer	1.47e-05	0.000161	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—UGT1A1—lung cancer	1.46e-05	0.000161	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CA—lung cancer	1.45e-05	0.00016	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—KRAS—lung cancer	1.43e-05	0.000158	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CG—lung cancer	1.42e-05	0.000156	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KIT—lung cancer	1.42e-05	0.000156	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APC—lung cancer	1.42e-05	0.000156	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP1A1—lung cancer	1.42e-05	0.000156	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—lung cancer	1.41e-05	0.000156	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GNG11—lung cancer	1.41e-05	0.000155	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.4e-05	0.000155	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ERCC2—lung cancer	1.4e-05	0.000154	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGF—lung cancer	1.4e-05	0.000154	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—APOA1—lung cancer	1.36e-05	0.00015	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—POMC—lung cancer	1.35e-05	0.000148	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALDOA—lung cancer	1.34e-05	0.000148	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—BRAF—lung cancer	1.33e-05	0.000147	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CA—lung cancer	1.32e-05	0.000145	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6R—lung cancer	1.32e-05	0.000145	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CREBBP—lung cancer	1.31e-05	0.000145	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MDM2—lung cancer	1.31e-05	0.000144	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RAF1—lung cancer	1.31e-05	0.000144	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NCOA3—lung cancer	1.31e-05	0.000144	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.3e-05	0.000143	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ERBB2—lung cancer	1.29e-05	0.000142	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.28e-05	0.000141	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MTOR—lung cancer	1.28e-05	0.00014	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CB—lung cancer	1.28e-05	0.00014	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ADCY1—lung cancer	1.27e-05	0.00014	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCG2—lung cancer	1.27e-05	0.00014	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAP2K1—lung cancer	1.25e-05	0.000138	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CD—lung cancer	1.25e-05	0.000137	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ENO2—lung cancer	1.25e-05	0.000137	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HPGDS—lung cancer	1.25e-05	0.000137	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CG—lung cancer	1.24e-05	0.000137	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPP2R1B—lung cancer	1.24e-05	0.000136	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCL8—lung cancer	1.23e-05	0.000135	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.22e-05	0.000134	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HRAS—lung cancer	1.22e-05	0.000134	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOA1—lung cancer	1.21e-05	0.000134	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTT1—lung cancer	1.21e-05	0.000133	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2A6—lung cancer	1.19e-05	0.000131	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GCLC—lung cancer	1.19e-05	0.000131	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.19e-05	0.000131	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AKT1—lung cancer	1.19e-05	0.00013	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—POMC—lung cancer	1.18e-05	0.00013	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CASP3—lung cancer	1.17e-05	0.000129	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL2—lung cancer	1.17e-05	0.000129	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6—lung cancer	1.17e-05	0.000128	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.16e-05	0.000128	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CREBBP—lung cancer	1.15e-05	0.000127	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCND1—lung cancer	1.14e-05	0.000126	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—JUN—lung cancer	1.14e-05	0.000125	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ENO1—lung cancer	1.13e-05	0.000124	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.13e-05	0.000124	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MDM2—lung cancer	1.12e-05	0.000123	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.11e-05	0.000122	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RAF1—lung cancer	1.11e-05	0.000122	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MMP9—lung cancer	1.11e-05	0.000122	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CG—lung cancer	1.11e-05	0.000122	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CDKN1A—lung cancer	1.11e-05	0.000122	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTEN—lung cancer	1.1e-05	0.000121	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ERBB2—lung cancer	1.1e-05	0.000121	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CD—lung cancer	1.09e-05	0.00012	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MTOR—lung cancer	1.09e-05	0.000119	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CB—lung cancer	1.09e-05	0.000119	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ALB—lung cancer	1.08e-05	0.000119	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AKT1—lung cancer	1.08e-05	0.000118	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—POMC—lung cancer	1.06e-05	0.000116	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EP300—lung cancer	1.05e-05	0.000116	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCL8—lung cancer	1.04e-05	0.000115	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CREBBP—lung cancer	1.03e-05	0.000113	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SRC—lung cancer	1.02e-05	0.000113	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2E1—lung cancer	1.01e-05	0.000112	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NQO1—lung cancer	1e-05	0.00011	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CASP3—lung cancer	9.99e-06	0.00011	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL2—lung cancer	9.97e-06	0.00011	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFA—lung cancer	9.97e-06	0.00011	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—STAT3—lung cancer	9.87e-06	0.000109	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NRAS—lung cancer	9.84e-06	0.000108	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.83e-06	0.000108	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CD—lung cancer	9.75e-06	0.000107	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.74e-06	0.000107	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCND1—lung cancer	9.72e-06	0.000107	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—JUN—lung cancer	9.7e-06	0.000107	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ALB—lung cancer	9.62e-06	0.000106	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CB—lung cancer	9.53e-06	0.000105	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS2—lung cancer	9.44e-06	0.000104	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MMP9—lung cancer	9.44e-06	0.000104	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAPK3—lung cancer	9.43e-06	0.000104	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CDKN1A—lung cancer	9.4e-06	0.000103	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTEN—lung cancer	9.38e-06	0.000103	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MYC—lung cancer	9.17e-06	0.000101	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—STK11—lung cancer	9.05e-06	9.95e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGFR—lung cancer	8.97e-06	9.87e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EP300—lung cancer	8.95e-06	9.84e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SRC—lung cancer	8.7e-06	9.57e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CB—lung cancer	8.5e-06	9.34e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.49e-06	9.34e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFA—lung cancer	8.47e-06	9.32e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KRAS—lung cancer	8.47e-06	9.32e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS2—lung cancer	8.42e-06	9.26e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—STAT3—lung cancer	8.39e-06	9.23e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NRAS—lung cancer	8.37e-06	9.21e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTP1—lung cancer	8.37e-06	9.21e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTEN—lung cancer	8.24e-06	9.06e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CAT—lung cancer	8.14e-06	8.96e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.1e-06	8.91e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAPK3—lung cancer	8.02e-06	8.82e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCB1—lung cancer	7.92e-06	8.71e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—EP300—lung cancer	7.85e-06	8.64e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MYC—lung cancer	7.8e-06	8.58e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CA—lung cancer	7.78e-06	8.56e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TYMS—lung cancer	7.78e-06	8.56e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTM1—lung cancer	7.69e-06	8.46e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGFR—lung cancer	7.63e-06	8.39e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TP53—lung cancer	7.53e-06	8.28e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTEN—lung cancer	7.34e-06	8.07e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP1A1—lung cancer	7.29e-06	8.02e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ERCC2—lung cancer	7.23e-06	7.95e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KRAS—lung cancer	7.2e-06	7.92e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HRAS—lung cancer	7.2e-06	7.92e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—EP300—lung cancer	7e-06	7.7e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6—lung cancer	6.89e-06	7.58e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CA—lung cancer	6.62e-06	7.28e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TP53—lung cancer	6.4e-06	7.04e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT1—lung cancer	6.36e-06	6.99e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOA1—lung cancer	6.26e-06	6.88e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HRAS—lung cancer	6.12e-06	6.74e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.99e-06	6.59e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6—lung cancer	5.86e-06	6.45e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CA—lung cancer	5.81e-06	6.39e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CG—lung cancer	5.71e-06	6.28e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—POMC—lung cancer	5.44e-06	5.98e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT1—lung cancer	5.41e-06	5.95e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CREBBP—lung cancer	5.3e-06	5.82e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CA—lung cancer	5.18e-06	5.7e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CD—lung cancer	5.02e-06	5.52e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALB—lung cancer	4.96e-06	5.45e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AKT1—lung cancer	4.75e-06	5.22e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CB—lung cancer	4.38e-06	4.81e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS2—lung cancer	4.34e-06	4.77e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AKT1—lung cancer	4.23e-06	4.65e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTEN—lung cancer	3.78e-06	4.16e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—EP300—lung cancer	3.61e-06	3.97e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CA—lung cancer	2.67e-06	2.93e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AKT1—lung cancer	2.18e-06	2.4e-05	CbGpPWpGaD
